Serum vitamin D, magnesium and calcium on lung function and QoL in COPD: A cross-sectional study Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014
Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Vitamin D, exacerbations and hospitalizations in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Longitudinal changes in COPD patients in primary care Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Vitamin D status in COPD patients admitted for exacerbation Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
Profile of serum vitamin D levels in stable COPD patients Source: International Congress 2016 – Best abstracts in COPD management Year: 2016
Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
Validation of the COPD control concept: A UK pilot Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016
Vitamin E supplement usage and pulmonary outcomes in COPDGene Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014
The effect of Vitamin D deficiency on lung function in current smoker COPD patients Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014
Is vitamin D deficiency a risk factor for COPD exacerbations? Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease Year: 2013
Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013
Comparison of COPD patients with high and low symptoms from a real-world US survey Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015
Do inhaled corticosteroids reduce the frequent exacerbator phenotype in COPD - A little help by a multicenter survey Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
COPD: Influence of patients’ nutritive status on the exacerbations rate Source: International Congress 2016 – COPD diagnosis and management Year: 2016
Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015
Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014